Health-care stocks continue to dominate our list of top charts to watch.
Arbutus Biopharma Corp. ABUS, +8.49% jumped 25 cents, or 2.8%, to $9.05 on Tuesday on 597,300 shares traded, nearly double its average volume. The hepatitis-drug company announced updates on several key milestones ahead of its afternoon presentation at Roivant Pipeline Day in New York City. The stock last month broke out of a more than six-month base pattern, and is now in a steep rising channel. Next target is $10.50-$11. Support on any pullback would be $8.20-$8.25.
Marinus Pharmaceuticals Inc. MRNS, -2.38% popped 63 cents, or 8.5%, to $8.04 on over 1 million shares traded Tuesday. The move came on no news from the developer of therapeutics to treat epilepsy and neuropsychiatric disorders. The stock, which bottomed in March after a three-month down move, had a particularly strong run in late May and early June, and has since consolidated. A break over the June 8 high of $8.25 could get the stock to next lateral resistance just under $10.
Neptune Technologies & Bioressources Inc. NEPT, +6.81% edged up 18 cents to $3.23 on just under 800,000 shares traded Tuesday on no news. The Quebec-based wellness-products company saw its stock break out three weeks ago on news of a new multiyear agreement with Canopy Growth CGC, +0.00% to provide extracted cannabis products. The stock has since been consolidating the gains, and needs to get over lateral resistance at around $3.45 to make another run at its June 20 high just under $4.50.
OPKO Health Inc. OPK, +3.33% gained 27 cents to $5.79 on 9.3 million shares traded Tuesday. There was no news from the health-care company, which engages in the diagnostics and pharmaceuticals business. The stock, which has been rallying since releasing better-than-expected earnings in early May, has broken out of a multi-year downtrend, and looks poised for more upside. Next targets are $6.50, followed by $7.50.
